Organisation paid for research Program year 2023 Source: CMS Open Payments

Vital Pharma Research, Inc.

Neither a doctor nor a teaching hospital

Research payments

$1,087,036

69 payments

Through program year 2023, Vital Pharma Research, Inc. is reported as receiving $1,087,036 in research payments, across 69 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$937,666	57
2022	Research	$148,705	9
2021	Research	$171	1
2019	Research	$495	2

Breakdown

Who paid Research payments · program years 2019–2023

Exeltis, USA Inc. $1,086,371 66 payments
Incyte Corporation $665 3 payments

Studies the money was for Research payments · program years 2019–2023

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $937,666 57 payments
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $148,705 9 payments
Prospective, Non Interventional Study of Disease Progression and Treatment of Patients With Polycythemia Vera in United States Academic Or Community Clinical Practices $665 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.